1295 related articles for article (PubMed ID: 29605187)
1. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
[TBL] [Abstract][Full Text] [Related]
3. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A
Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949
[TBL] [Abstract][Full Text] [Related]
4. Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCT.
Morrison AP; Pyle M; Byrne R; Broome M; Freeman D; Johns L; James A; Husain N; Whale R; MacLennan G; Norrie J; Hudson J; Peters S; Davies L; Bowe S; Smith J; Shiers D; Joyce E; Jones W; Hollis C; Maughan D
Health Technol Assess; 2021 Jan; 25(4):1-124. PubMed ID: 33496261
[TBL] [Abstract][Full Text] [Related]
5. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis.
Freeman D; Dunn G; Startup H; Pugh K; Cordwell J; Mander H; Černis E; Wingham G; Shirvell K; Kingdon D
Lancet Psychiatry; 2015 Apr; 2(4):305-13. PubMed ID: 26360083
[TBL] [Abstract][Full Text] [Related]
6. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe S; French P; Hutton P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TR; Davies L; Shields G; Buck D; Tully S; Kingdon D
Health Technol Assess; 2019 Feb; 23(7):1-144. PubMed ID: 30806619
[TBL] [Abstract][Full Text] [Related]
7. Cognitive behavioural therapy without medication for schizophrenia.
Bighelli I; Çıray O; Salahuddin NH; Leucht S
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD015332. PubMed ID: 38323679
[TBL] [Abstract][Full Text] [Related]
8. A targeted psychological treatment for sleep problems in young people at ultra-high risk of psychosis in England (SleepWell): a parallel group, single-blind, randomised controlled feasibility trial.
Waite F; Černis E; Kabir T; Iredale E; Johns L; Maughan D; Diamond R; Seddon R; Williams N; Yu LM; Freeman D;
Lancet Psychiatry; 2023 Sep; 10(9):706-718. PubMed ID: 37562423
[TBL] [Abstract][Full Text] [Related]
9. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.
Barkham M; Saxon D; Hardy GE; Bradburn M; Galloway D; Wickramasekera N; Keetharuth AD; Bower P; King M; Elliott R; Gabriel L; Kellett S; Shaw S; Wilkinson T; Connell J; Harrison P; Ardern K; Bishop-Edwards L; Ashley K; Ohlsen S; Pilling S; Waller G; Brazier JE
Lancet Psychiatry; 2021 Jun; 8(6):487-499. PubMed ID: 34000240
[TBL] [Abstract][Full Text] [Related]
10. Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14-18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS).
Pyle M; Broome MR; Joyce E; MacLennan G; Norrie J; Freeman D; Fowler D; Haddad PM; Shiers D; Hollis C; Smith J; Liew A; Byrne RE; French P; Peters S; Hudson J; Davies L; Emsley R; Yung A; Birchwood M; Longden E; Morrison AP
Trials; 2019 Jul; 20(1):395. PubMed ID: 31272477
[TBL] [Abstract][Full Text] [Related]
11. Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial.
Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe SE; French P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TRE; Davies L; Kingdon D;
Lancet Psychiatry; 2018 Aug; 5(8):633-643. PubMed ID: 30001930
[TBL] [Abstract][Full Text] [Related]
12. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial.
Goldstein LH; Robinson EJ; Mellers JDC; Stone J; Carson A; Reuber M; Medford N; McCrone P; Murray J; Richardson MP; Pilecka I; Eastwood C; Moore M; Mosweu I; Perdue I; Landau S; Chalder T;
Lancet Psychiatry; 2020 Jun; 7(6):491-505. PubMed ID: 32445688
[TBL] [Abstract][Full Text] [Related]
13. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial.
Morrison AP; Turkington D; Pyle M; Spencer H; Brabban A; Dunn G; Christodoulides T; Dudley R; Chapman N; Callcott P; Grace T; Lumley V; Drage L; Tully S; Irving K; Cummings A; Byrne R; Davies LM; Hutton P
Lancet; 2014 Apr; 383(9926):1395-403. PubMed ID: 24508320
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
15. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
[TBL] [Abstract][Full Text] [Related]
16. Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.
Johnsen E; Kroken RA; Løberg EM; Rettenbacher M; Joa I; Larsen TK; Reitan SK; Walla B; Alisauskiene R; Anda LG; Bartz-Johannessen C; Berle JØ; Bjarke J; Fathian F; Hugdahl K; Kjelby E; Sinkeviciute I; Skrede S; Stabell L; Steen VM; Fleischhacker WW
Lancet Psychiatry; 2020 Nov; 7(11):945-954. PubMed ID: 33069317
[TBL] [Abstract][Full Text] [Related]
17. Early intervention for psychosis.
Marshall M; Rathbone J
Cochrane Database Syst Rev; 2006 Oct; (4):CD004718. PubMed ID: 17054213
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.
Howard R; Cort E; Bradley R; Harper E; Kelly L; Bentham P; Ritchie C; Reeves S; Fawzi W; Livingston G; Sommerlad A; Oomman S; Nazir E; Nilforooshan R; Barber R; Fox C; Macharouthu AV; Ramachandra P; Pattan V; Sykes J; Curran V; Katona C; Dening T; Knapp M; Gray R;
Lancet Psychiatry; 2018 Jul; 5(7):553-563. PubMed ID: 29880238
[TBL] [Abstract][Full Text] [Related]
19. Virtual-reality-based cognitive behavioural therapy versus waiting list control for paranoid ideation and social avoidance in patients with psychotic disorders: a single-blind randomised controlled trial.
Pot-Kolder RMCA; Geraets CNW; Veling W; van Beilen M; Staring ABP; Gijsman HJ; Delespaul PAEG; van der Gaag M
Lancet Psychiatry; 2018 Mar; 5(3):217-226. PubMed ID: 29429948
[TBL] [Abstract][Full Text] [Related]
20. Pilot randomised controlled trial of culturally adapted cognitive behavior therapy for psychosis (CaCBTp) in Pakistan.
Husain MO; Chaudhry IB; Mehmood N; Rehman RU; Kazmi A; Hamirani M; Kiran T; Bukhsh A; Bassett P; Husain MI; Naeem F; Husain N
BMC Health Serv Res; 2017 Dec; 17(1):808. PubMed ID: 29207980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
